Prostate Cancer - Results from #25240

Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS) - Abstract August 7, 2012

Can a trained non-physician provider perform transrectal ultrasound-guided prostatic biopsies as effectively as an experienced urologist? - Abstract August 7, 2012

Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer - Abstract August 7, 2012

Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery - Abstract August 7, 2012

Late gastrointestinal and urogenital side-effects after radiotherapy - Incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer - Abstract August 7, 2012

OncoGenex announces initiation of the Phase 3 "AFFINITY" Trial for patients with advanced prostate cancer August 7, 2012

Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program - Abstract August 7, 2012

Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate - Abstract August 7, 2012

Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy - Abstract August 7, 2012

Magnetic resonance imaging-based treatment planning for prostate brachytherapy - Abstract August 7, 2012

T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations - Abstract August 7, 2012

Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer - Abstract August 7, 2012

PSA velocity and doubling time in diagnosis and prognosis of prostate cancer - Abstract August 6, 2012

Urologists and oncologists: Adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC) - Abstract August 6, 2012

Abiraterone for the treatment of metastatic castrate-resistant prostate cancer - Abstract August 6, 2012

Researchers discover new mechanism behind resistance to cancer treatment that could lead to better therapies August 6, 2012

Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy?: A systematic review - Abstract August 6, 2012

Vitamin D, PTH, and calcium and the risk of prostate cancer: A prospective nested case-control study - Abstract August 6, 2012

Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy - Abstract August 6, 2012

A molecular image-directed, 3D ultrasound-guided biopsy system for the prostate - Abstract August 6, 2012

Page 1263 of 1437